Scholz, CW; Pinto, A; Linkesch, W; Linden, O; Viardot, A; Keller, U; Hess, G; Lerch, K; Frigeri, F; Arcamone, M; Frericks, B; Pott, C; Pezzutto, A.
90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma, First Results from an International Phase II Clinical Trial
BLOOD. 2010; 116(21): 261-261.
Doi: 10.1182/blood.V116.21.593.593
Web of Science
FullText
FullText_MUG